QQ客服 官方微博 反馈留言

	Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis
	Xiang, Shizhao; Zhang, Ning; Yang, Zheng; Bian, Zhouyan; Yuan, Yuan; Tang, Qizhu
刊名	EXPERIMENTAL AND THERAPEUTIC MEDICINE
	2016
卷号	12期号:4
关键词	bisoprolol adrenoreceptor blocker cardiac fibrosis cardiac hypertrophy
ISSN号	1792-0981
DOI	10.3892/etm.2016.3570
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4114365
专题	武汉大学
推荐引用方式 GB/T 7714	Xiang, Shizhao,Zhang, Ning,Yang, Zheng,et al. Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2016,12(4).
APA	Xiang, Shizhao,Zhang, Ning,Yang, Zheng,Bian, Zhouyan,Yuan, Yuan,&Tang, Qizhu.(2016).Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis.EXPERIMENTAL AND THERAPEUTIC MEDICINE,12(4).
MLA	Xiang, Shizhao,et al."Achievement of a target dose of bisoprolol may not be a preferred option for attenuating pressure overload-induced cardiac hypertrophy and fibrosis".EXPERIMENTAL AND THERAPEUTIC MEDICINE 12.4(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。